BICO Group, headquartered in Sweden, is a pioneer in the field of bio-convergence. The company provides innovative technologies and solutions for bioprinting, lab automation, and cell culture to accelerate life science research and drug development.
Date confirmed from the financial calendar in the company's interim report as filed with the Swedish FSA (FI Börsinformation).
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
BICO Group is scheduled to report its next quarterly earnings on 11/11/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
BICO Group last reported quarterly earnings on 8/19/2026 (Q2 2026). Earnings per share (EPS) came in at -0.50 SEK.
Across its last 4 earnings reports, BICO Group stock moved by ±12.5% on average the following day. The largest reaction was +13.8% on 11/04/2025; 4 of 4 reactions were positive.
BICO Group has beaten analyst EPS estimates in 1 of its last 4 evaluated quarters (beat rate: 25%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 4 report dates (close to close).
Basis: 4 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.